|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/42 | |
| A61K 39/395 | |||
| A61P 37/08 | |||
| A61K 39/00 |
| (11) | Patento numeris | 2703415 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13185738.5 |
| Europos patento paraiškos padavimo data | 2009-09-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-03-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-03-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 97819 P | 2008-09-17 | US |
| (72) |
Desjarlais, John R., US
Chu, Seung Y., US
Horton, Holly M., US
|
| (73) |
Xencor, Inc.,
111 W. Lemon Avenue, Monrovia, CA 91016,
US
|
| (54) | Compositions and methods for treating IgE-mediated disorders |
| Compositions and methods for treating IgE-mediated disorders |